Nothing Special   »   [go: up one dir, main page]

EP1086215A4 - Herstellung und verwendung höherer vaccine - Google Patents

Herstellung und verwendung höherer vaccine

Info

Publication number
EP1086215A4
EP1086215A4 EP99937160A EP99937160A EP1086215A4 EP 1086215 A4 EP1086215 A4 EP 1086215A4 EP 99937160 A EP99937160 A EP 99937160A EP 99937160 A EP99937160 A EP 99937160A EP 1086215 A4 EP1086215 A4 EP 1086215A4
Authority
EP
European Patent Office
Prior art keywords
preparation
superior vaccines
vaccines
superior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99937160A
Other languages
English (en)
French (fr)
Other versions
EP1086215A2 (de
Inventor
Bruce L Roberts
Srinivas Shankara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of EP1086215A2 publication Critical patent/EP1086215A2/de
Publication of EP1086215A4 publication Critical patent/EP1086215A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP99937160A 1998-06-19 1999-06-18 Herstellung und verwendung höherer vaccine Withdrawn EP1086215A4 (de)

Applications Claiming Priority (59)

Application Number Priority Date Filing Date Title
US9008098P 1998-06-19 1998-06-19
US9007798P 1998-06-19 1998-06-19
US9004098P 1998-06-19 1998-06-19
US8985398P 1998-06-19 1998-06-19
US9004898P 1998-06-19 1998-06-19
US9004798P 1998-06-19 1998-06-19
US9000098P 1998-06-19 1998-06-19
US8983398P 1998-06-19 1998-06-19
US9003698P 1998-06-19 1998-06-19
US8984498P 1998-06-19 1998-06-19
US9007998P 1998-06-19 1998-06-19
US9004198P 1998-06-19 1998-06-19
US9003998P 1998-06-19 1998-06-19
US8999498P 1998-06-19 1998-06-19
US9003598P 1998-06-19 1998-06-19
US8999798P 1998-06-19 1998-06-19
US9007898P 1998-06-19 1998-06-19
US8999198P 1998-06-19 1998-06-19
US9007698P 1998-06-19 1998-06-19
US9004298P 1998-06-19 1998-06-19
US8987898P 1998-06-19 1998-06-19
US8999998P 1998-06-19 1998-06-19
US9004398P 1998-06-19 1998-06-19
US9007298P 1998-06-19 1998-06-19
US8999398P 1998-06-19 1998-06-19
US8999298P 1998-06-19 1998-06-19
US9004498P 1998-06-19 1998-06-19
US9004598P 1998-06-19 1998-06-19
US90045P 1998-06-19
US89853P 1998-06-19
US90078P 1998-06-19
US90000P 1998-06-19
US90039P 1998-06-19
US90072P 1998-06-19
US90077P 1998-06-19
US89833P 1998-06-19
US89878P 1998-06-19
US89994P 1998-06-19
US89999P 1998-06-19
US89844P 1998-06-19
US90043P 1998-06-19
US90042P 1998-06-19
US89991P 1998-06-19
US90044P 1998-06-19
US90076P 1998-06-19
US89997P 1998-06-19
US90041P 1998-06-19
US89992P 1998-06-19
US89993P 1998-06-19
US90080P 1998-06-19
US90036P 1998-06-19
US90040P 1998-06-19
US90035P 1998-06-19
US90047P 1998-06-19
US90048P 1998-06-19
US11171598P 1998-12-08 1998-12-08
US111715P 1998-12-08
PCT/US1999/013800 WO1999065924A2 (en) 1998-06-19 1999-06-18 Preparation and use of superior vaccines
US90079P 2008-08-19

Publications (2)

Publication Number Publication Date
EP1086215A2 EP1086215A2 (de) 2001-03-28
EP1086215A4 true EP1086215A4 (de) 2005-10-19

Family

ID=27586849

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99937160A Withdrawn EP1086215A4 (de) 1998-06-19 1999-06-18 Herstellung und verwendung höherer vaccine

Country Status (5)

Country Link
EP (1) EP1086215A4 (de)
JP (1) JP2002534056A (de)
AU (2) AU4825699A (de)
CA (1) CA2335452A1 (de)
WO (1) WO1999065924A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6825333B1 (en) 1999-08-20 2004-11-30 Chiron Corporation EGFH2 genes and gene products
US7041445B2 (en) * 1999-11-15 2006-05-09 Clontech Laboratories, Inc. Long oligonucleotide arrays
AU2001249493A1 (en) * 2000-03-28 2001-10-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6632630B2 (en) 2000-03-29 2003-10-14 Aclara Biosciences, Inc. Monooxygenase assays
MXPA04010415A (es) * 2002-04-22 2005-02-17 Bioniche Life Sciences Inc Composiciones oligonucleotdias y su uso para la modulacion de respuestas inmunes.
US7198899B2 (en) 2002-06-03 2007-04-03 Chiron Corporation Use of NRG4, or inhibitors thereof, in the treatment of colon and pancreatic cancers
WO2008047128A2 (en) * 2006-10-18 2008-04-24 Nazneen Rahman Materials and methods for determining susceptibility to cancer
AU2010307020B2 (en) * 2009-10-12 2015-09-24 Medimmune, Llc Quantification of IR-A and IR-B for tumor classification
EP2322656A1 (de) * 2009-11-17 2011-05-18 Centre National de la Recherche Scientifique (C.N.R.S) Verfahren zur Diagnose von Hautkrankheiten

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761822A2 (de) * 1995-09-12 1997-03-12 The Johns Hopkins University School Of Medicine Reihenanalyse-Verfahren der Genexpression

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940598A1 (de) * 1989-12-08 1991-06-13 Behringwerke Ag Toxoplasma gondii-antigene, ihre herstellung und ihre verwendung
EP0437427A4 (en) * 1985-10-30 1992-07-01 Biogen, Inc. Cleaved dimers of mullerian inhibiting substance-like polypeptides
WO1989008114A1 (en) * 1988-02-25 1989-09-08 The General Hospital Corporation Rapid immunoselection cloning method
WO1989008254A1 (en) * 1988-03-04 1989-09-08 La Jolla Cancer Research Foundation Germ cell alkaline phosphatase gene and protein produced thereby
EP0359919B1 (de) * 1988-06-29 1996-02-28 Ml Technology Ventures, L.P. Rekombinantes hyopneumoniae Antigen und dessen Verwendung
ES2075016T3 (es) * 1988-08-23 1995-10-01 Dana Farber Cancer Inst Inc La subunidad alfa del receptor de adherencia a leucocitos lfa-1.
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
WO1991008217A1 (en) * 1989-12-05 1991-06-13 The Regents Of The University Of California Human intestinal mucins
WO1992000387A1 (en) * 1990-06-29 1992-01-09 The Regents Of The University Of Michigan Neurofibromatosis gene

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0761822A2 (de) * 1995-09-12 1997-03-12 The Johns Hopkins University School Of Medicine Reihenanalyse-Verfahren der Genexpression

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
FRAIJ BASSAM M ET AL: "A retinoic acid-inducible mRNA from human erythroleukemia cells encodes a novel tissue transglutaminase homologue", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 267, no. 31, 1992, pages 22616 - 22623, XP002324843, ISSN: 0021-9258 *
See also references of WO9965924A3 *
VELCULESCU V E ET AL: "SERIAL ANALYSIS OF GENE EXPRESSION", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 270, no. 5235, 20 October 1995 (1995-10-20), pages 484 - 487, XP001024449, ISSN: 0036-8075 *

Also Published As

Publication number Publication date
AU4825699A (en) 2000-01-05
AU5204499A (en) 2000-01-05
WO1999065924A2 (en) 1999-12-23
EP1086215A2 (de) 2001-03-28
WO1999065924A3 (en) 2000-04-13
CA2335452A1 (en) 1999-12-23
JP2002534056A (ja) 2002-10-15

Similar Documents

Publication Publication Date Title
EP1112091A4 (de) Schnelle tieftemperatur-drucksterilisation und impfstoffherstellung
HUP0200898A2 (en) Derivatives of venlafaxine and methods of preparing and using the same
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
HUP0103357A3 (en) Halichondrin analogs and methods of their use and preparation
HUP0003972A3 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
EP1227821A4 (de) Therapeutische zusammensetzungen und verfahren zur verwendung davon
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
ZA982478B (en) Compounds their use and preparation
IL147503A0 (en) Oxazolidinone compounds and methods of preparation and use thereof
IL148247A (en) Vaccine and its uses
EP1183030A4 (de) Verfahren zur herstellung und ihre verwenung von n-desmethylzopiclone
HU229606B1 (en) Novel combination of loteprednol and antihistamines
GB9806666D0 (en) Antigen preparation and use
GB9819898D0 (en) New vaccine and method of use
HUP0201105A3 (en) Pesticidal solvates of pymetrozine, preparation and use thereof
IL144845A0 (en) Vaccines and gene therapy compositions and methods of making and using the same
EP1086215A4 (de) Herstellung und verwendung höherer vaccine
EP1161451A4 (de) Menschliches alpha-endokin und verfahren zu seiner verwendung
HUP9800146A3 (en) Thalidomide-derivatives and use of them
AU7410900A (en) Alginate preparation and use of the same
CZ20011896A3 (cs) Imunogenní prostředek a protilátka
HUP0103309A3 (en) Novel salts of n-tert-butylhydroxylamine and preparation thereof
IL131719A0 (en) Iren protein its preparation and use
HUP9902855A3 (en) Preparation of sterol- and stanol-esters
GB9912167D0 (en) Antiperspirant salts and methods of their preparation

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001219

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20050901

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061031